Second American infected with Ebola en route to US

August 5, 2014
Dr. Kent Brantly and his wife, Amber, are seen in an undated photo provided by Samaritan's Purse. Brantly became the first person infected with Ebola to be brought to the United States from Africa, arriving at at Emory University Hospital, in Atlanta on Saturday, Aug. 2, 2014. Fellow aid worker Nancy Writebol was expected to arrive in several days. (AP Photo/Samaritan's Purse)

The second American aid worker recently diagnosed with Ebola in west Africa is en route to Atlanta.

A chartered plane specially equipped to contain took off at 1:12 a.m. local time (9:12 p.m. EDT Monday) from the airport in Liberia's capital, Monrovia. An Associated Press reporter saw the four-vehicle convoy arrive at the airport.

Although hospital officials haven't released the patient's identity, the aid group she was working with has identified her as 59-year-old Nancy Writebol.

Writebol will be treated at a special isolation unit at Emory University Hospital in Atlanta. Dr. Kent Brantly was taken to the unit Saturday after arriving from Liberia aboard the same aircraft.

Brantly and Writebol contracted Ebola while treating patients at a missionary clinic in Liberia.

Both are being treated with an experimental drug never tested for safety in humans.

Explore further: US doctor in Africa tests positive for Ebola

Related Stories

US Ebola patient 'seems to be improving': CDC chief

August 3, 2014

A US doctor infected with the Ebola virus "seems to be improving," a top US health official said Sunday after the aid worker was flown back to the United States from Africa for treatment.

Recommended for you

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Mosquitoes, Zika and biotech regulation

September 19, 2016

In a new Policy Forum article in Science, NC State professor Jennifer Kuzma argues that federal authorities are missing an opportunity to revise outdated regulatory processes not fit for modern innovations in biotechnology, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.